Authors:
Cuervo, NS
Guillot, S
Romanenkova, N
Combiescu, M
Aubert-Combiescu, A
Seghier, M
Caro, V
Crainic, R
Delpeyroux, F
Citation: Ns. Cuervo et al., Genomic features of intertypic recombinant Sabin poliovirus strains excreted by primary vaccinees, J VIROLOGY, 75(13), 2001, pp. 5740-5751
Authors:
Shulman, LM
Manor, Y
Handsher, R
Delpeyroux, F
McDonough, MJ
Halmut, T
Silberstein, I
Alfandari, J
Quay, J
Fisher, T
Robinov, J
Kew, OM
Crainic, R
Mendelson, E
Citation: Lm. Shulman et al., Molecular and antigenic characterization of a highly evolved derivative ofthe type 2 oral poliovaccine strain isolated from sewage in Israel, J CLIN MICR, 38(10), 2000, pp. 3729-3734
Authors:
Delpeyroux, F
Guillot, S
Szendroi, A
Balanant, J
Caro, V
Cuervo, N
Chevaliez, S
Dahourou, G
Crainic, R
Citation: F. Delpeyroux et al., What are the repercussions of the oral polio vaccine on the world of enteroviruses?, B S PATH EX, 93(3), 2000, pp. 193-197
Authors:
Merten, OW
Kallel, H
Manuguerra, JC
Tardy-Panit, M
Crainic, R
Delpeyroux, F
Van der Werf, S
Perrin, P
Citation: Ow. Merten et al., The new medium MDSS2N, free of any animal protein supports cell growth andproduction of various viruses, CYTOTECHNOL, 30(1-3), 1999, pp. 191-201
Authors:
Desmezieres, E
Jacob, Y
Saron, MF
Delpeyroux, F
Tordo, N
Perrin, P
Citation: E. Desmezieres et al., Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines, J GEN VIROL, 80, 1999, pp. 2343-2351